Julia Shi, MD, FACP

She has served as the Medical Director of primary care services at the APT Foundation in New Haven Connecticut since completion of her substance abuse fellowship in 1992. She was involved with the initial clinical trial phase of buprenorphine in the early 1990s and established outpatient detoxification protocols for opioid users. She continues to participate in numerous NIH sponsored research projects in substance abuse – clinical investigator for the Psychotherapy Development Center and Yale Behavioral Pharmacology Laboratory. Her clinical role focuses on improving the treatment and care of patients with addiction and its associated comorbidities at the Central Medical Unit. This clinic is a national model delivering outpatient primary care within an addiction treatment center which offers methadone and buprenorphine for opioid use disorder treatment, outpatient detoxification in addition to general primary care.

She provides outpatient educational experiences to a wide variety of trainees, including medical students, internal medicine residents, and psychiatry and addiction fellows at the APT Foundation. She is part of the core faculty in the Program in Addiction Medicine and the ACGME accredited Addiction Medicine Fellowship, housed within the GIM section.

She has received national award for her outstanding contributions for opioid treatment and Yale award for her teaching for medical students.